HR Execs on the Move

Mental Health Centers of Western Illinois

www.mhcwi.org

 
Mental Health Centers of Western Illinois is a Pittsfield, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.mhcwi.org
  • 120N Williams Dr
    Pittsfield, IL USA 62363
  • Phone: 217.285.4930

Executives

Name Title Contact Details

Similar Companies

Equian

One of our nation’s most pressing challenges is the rising cost and affordability of healthcare. At Equian, our efforts are dedicated to addressing this challenge. We provide solutions that ensure each healthcare interaction is paid accurately and at the lowest possible cost. We have a proven system to reduce healthcare cost through proprietary data analytics coupled with deep domain expertise. Once we have aligned with you and analyzed all of the data, we provide integrated payment integrity solutions that eliminate unnecessary spending.

Invent Bio-Med

Invent Bio-Med is a Lake Forest, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Caring Companions

Caring Companions is a Youngwood, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Wabash County Hospital

Wabash County Hospital is a county-owned, critical access hospital. With 25 inpatient beds, we offer critical care services, emergency services, cancer treatment and much more.

Versartis

Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.